Cefoperazone induces esterase B expression by EstR and esterase B enhances cefoperazone activity at the periplasm. Toewiwat N, Whangsuk W, Ploypradith P, Mongkolsuk S, Loprasert S. Int J Med Microbiol. 2020 Feb;310(2):151396. doi: 10.1016/j.ijmm.2020.151396. Epub 2020 Jan 23. PMID: 32005588

28 Dec 2020
0
0

Cefoperazone induces esterase B expression by EstR and esterase B enhances cefoperazone activity at the periplasm.
Toewiwat N, Whangsuk W, Ploypradith P, Mongkolsuk S, Loprasert S.
Int J Med Microbiol. 2020 Feb;310(2):151396. doi: 10.1016/j.ijmm.2020.151396. Epub 2020 Jan 23.
PMID: 32005588

Tags

Share this

Related Posts

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S, Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.
28 Dec 2015
0

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S, Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.

Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance inStenotrophomonas maltophilia. Srijaruskul K, Charoenlap N, Namchaiw P, Chattrakarn S, Giengkam S,Mongkolsuk S, Vattanaviboon P. PLoS One. 2015 Apr 27;10(4):e0123699. doi: 10.1371/journal.pone.0123699.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More